Source link : https://newshealth.biz/health-news/adjuvant-combination-for-kidney-cancer-gets-fdas-blessing/
The FDA on Friday approved belzutifan (Welireg) plus pembrolizumab (Keytruda, Keytruda Qlex) as adjuvant therapy for renal cell carcinoma (RCC) with a clear cell component. Based on results from LITESPARK-022, the combination is indicated for adults at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions. The phase […]
The post Adjuvant Combination for Kidney Cancer Gets FDA’s Blessing first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-12 21:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8